The last time I sent anything to Cytodyn was about leronlimab possibly acting as an antiviral in Covid way back on 8/1/2020. I did receive a reply back from Dr. Kelly and he said it was interesting and the Company would take a look at it.

Leronlimab Blockade Downregulates mTOR Disrupting Viral Replication

I week ago I was looking back at a publication from January 2021 on leronlimab in breast cancer and ran across this -

Quote:

---

The induction of the PI3K pathway and thereby PDK1 and serine/threonine kinase protein kinase B (AKT) pathway, by CCR5, in turn, induces cell survival, glycolysis, cell proliferation, growth and proliferation of progenitor and stem cells, immune cell differentiation, and the release of eIF4E to promote cap-dependent translation.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825185/

---

Which certainly supports my prior conclusion.